AJOG: Aspirin 162 mg versus 81 mg for Preeclampsia Prophylaxis in High-risk Obese Individuals: A Comparative Effectiveness Open Label Randomized Trial (ASPREO)

Aspirin 162 mg versus 81 mg for Preeclampsia Prophylaxis in High-risk Obese Individuals: A Comparative Effectiveness Open Label Randomized Trial (ASPREO) – American Journal of Obstetrics & Gynecology (ajog.org) ABSTRACT:…

Read More from AJOG: Aspirin 162 mg versus 81 mg for Preeclampsia Prophylaxis in High-risk Obese Individuals: A Comparative Effectiveness Open Label Randomized Trial (ASPREO)

Screening for Hypertensive Disorders of Pregnancy -US Preventive Services Task Force Final Recommendation Statement

Abstract Importance  Hypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. The rate of hypertensive disorders of pregnancy has been increasing from approximately…

Read More from Screening for Hypertensive Disorders of Pregnancy -US Preventive Services Task Force Final Recommendation Statement